Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Afya ( (AFYA) ) has issued an announcement.
On November 7, 2025, Afya Limited announced that the Ministry of Education’s Secretary of Regulation and Supervision of Higher Education authorized an increase of 100 medical seats at ITPAC Porto Nacional in Bragança, Pará. This expansion brings the total to 150 seats on this campus and 3,753 approved seats overall, reinforcing Afya’s commitment to quality medical education and its position as a leading medical education provider in Brazil.
The most recent analyst rating on (AFYA) stock is a Buy with a $25.50 price target. To see the full list of analyst forecasts on Afya stock, see the AFYA Stock Forecast page.
Spark’s Take on AFYA Stock
According to Spark, TipRanks’ AI Analyst, AFYA is a Outperform.
Afya’s strong financial performance and positive earnings call are the most significant factors driving the score. The company’s robust revenue growth, efficient cost management, and strategic initiatives like the share repurchase program highlight its potential for future growth. Technical analysis and valuation are supportive but less impactful, with the stock showing neutral momentum and reasonable valuation metrics.
To see Spark’s full report on AFYA stock, click here.
More about Afya
Afya is a leading medical education group in Brazil, providing a comprehensive ecosystem for medical students and professionals. The company offers a range of services from medical school education to residency preparation, continuing education, and medical practice solutions, empowering physicians throughout their careers.
Average Trading Volume: 101,324
Technical Sentiment Signal: Sell
Current Market Cap: $1.3B
Learn more about AFYA stock on TipRanks’ Stock Analysis page.